𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Histopathologic effect of preoperative chemotherapy using 5-Fu fat emulsion in gastric cancer

✍ Scribed by Yong-Fang Wu; Zhuan-An Zhen; Jia-Kang Shao; Hong-De Zhen; Zhi-Hong Han


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
330 KB
Volume
29
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis


The authors report histopathologic effect of preoperative chemotherapy using 5-Fu fat emulsion for a series of 42 cases of gastric carcinoma. To each patient 348-464 mg of 5-Fu emulsion was given orally every day for 10 days before operation. It was well tolerated and no apparent side-effects were encountered. The overall response rate was 57.14%. We hold that this regimen is beneficial for gastric cancer.


πŸ“œ SIMILAR VOLUMES


Effect of preoperative intralesional BCG
✍ Dr. Yeu-Tsu N. Lee πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 438 KB

In No. 13762 mammary adenocarcinoma, it has been shown that the combination of tumor infiltration with BCG and of subsequent surgery is more curative than either treatment modality alone. And the administration of postoperative systemic 5-fluorouracil (D-FU) is equally effective in eliminating the v

Effects of preoperative chemotherapy on
✍ Keiichi Kubota; Toshiro Konishi; Masanori Teruya; Masatoshi Makuuchi; Teruaki Ok πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 798 KB

The effects of preoperative chemotherapy on gastric and colonic cancers have yet to be evaluated fully. In this study, its effects were assessed by studying DNA ploidy patterns, cell cycles, and histological findings in such patients. Thirty-nine patients with gastric or colonic cancer were given pr

HIF-1Ξ± is an unfavorable determinant of
✍ Jun Nakamura; Yoshihiko Kitajima; Keita Kai; Kazuyoshi Hashiguchi; Masatsugu Hir πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 707 KB

## Abstract Among several chemotherapeutic agents, 5‐fluorouracil (5‐FU) has been widely used as a key drug in adjuvant chemotherapy for gastric cancer. However, no reliable marker, which predicts the response to 5‐FU in an adjuvant setting, has been identified. Hypoxia‐induced drug resistance, __v